| Literature DB >> 35815472 |
Emily K Armstrong1,2, Julie Mondon1, Adam D Miller1,3, Andrew T Revill2, Sarah A Stephenson4, Mun Hua Tan1,3, Paul Greenfield5, Jared J Tromp1, Patricia Corbett1, Sharon E Hook2.
Abstract
Oil spills pose a significant threat to marine biodiversity. Crude oil can partition into sediments where it may be persistent, placing benthic species such as decapods at particular risk of exposure. Transcriptomic and histological tools are often used to investigate the effects of hydrocarbon exposure on marine organisms following oil spill events, allowing for the identification of metabolic pathways impacted by oil exposure. However, there is limited information available for decapod crustaceans, many of which carry significant economic value. In the present study, we assess the sublethal impacts of crude oil exposure in the commercially important Australian greentail prawn (Metapenaeus bennettae) using transcriptomic and histological analyses. Prawns exposed to light, unweathered crude oil "spiked" sediments for 90 h were transferred to clean sediments for a further 72 h to assess recovery. Chemical analyses indicated that polycyclic aromatic hydrocarbons increased by approximately 65% and 91% in prawn muscle following 24 and 90 h of exposure, respectively, and significantly decreased during 24- and 72-h recovery periods. Transcriptomic responses followed an exposure and recovery pattern with innate immunity and nutrient metabolism transcripts significantly lowered in abundance after 24 h of exposure and were higher in abundance after 72 h of recovery. In addition, transcription/translation, cellular responses, and DNA repair pathways were significantly impacted after 24 h of exposure and recovered after 72 h of recovery. However, histological alterations such as tubule atrophy indicated an increase in severity after 24 and 72 h of recovery. The present study provides new insights into the sublethal impacts of crude oil exposure in greentail prawns and identifies molecular pathways altered by exposure. We expect these findings to inform future management associated with oil extraction activity and spills. Environ Toxicol Chem 2022;41:2162-2180.Entities:
Keywords: Decapods; Immune response; KEGG pathway; RNA; Shrimp; Tubule atrophy
Mesh:
Substances:
Year: 2022 PMID: 35815472 PMCID: PMC9545365 DOI: 10.1002/etc.5413
Source DB: PubMed Journal: Environ Toxicol Chem ISSN: 0730-7268 Impact factor: 4.218
Figure 1Flow chart depicting the outline of the laboratory trials undertaken at the South Australian Research and Development Institute in Adelaide. Sixty prawns were separated into three treatment groups, control, low (sediment spiked with 0.5 mg/kg of crude oil), and high (sediment spiked with 2 mg/kg of crude oil). One prawn from each of the five replicate tanks was taken for subsequent analysis after each exposure time points (24 and 90 h of exposure). Remaining prawns were then transferred to tanks with clean sediment, and one prawn was collected after each recovery time point (24 and 72 h of recovery).
Semiquantitative scale for epithelial lifting on gill lamellae in the greentail prawn
| Score | Description |
|---|---|
| 0 | No lifting of the majority of lamellae |
| 1 | Low‐level lifting, significantly less than one half of lamellae have lifting |
| 2 | Moderate‐level lifting, approximately half of lamellae have lifting |
| 3 | High‐level lifting, significantly more than one half of lamellae have lifting |
| 4 | Severe‐level lifting, all lamellae have lifting |
Figure 2Polycyclic aromatic hydrocarbon (PAH) concentrations (ng/g) measured in the control, low (nominal concentration of 0.5 mg/kg), high (nominal concentration of 2 mg/kg), and higher concentrations (scale from 0 to 1800 ng/g) of source oil (Northwest Shelf 2). N = naphthalene; P = phenanthrene; F = fluorene; DBT = dibenzothiophene; C1–C4 indicate the alkyl congeners for each PAH.
Figure 3Naphthalene and phenanthrene concentrations (ng/g) measured in prawn muscle tissues after both exposure and recovery periods. Significant differences (p > 0.05) between treatments for individual exposure and recovery time points are indicated by letters.
Figure 4Top 20 differentially abundant transcripts for each pairwise comparison. Colour bar indicates the abundances of the transcripts, red = high and blue = low; (A) 24 h of exposure control versus 2 mg/kg, (B) 90 h of exposure control versus 2 mg/kg, and (C) 72 h of recovery control versus 2 mg/kg. ACDH‐6 = acyl‐CoA dehydrogenase 6; Act4C = cytoplasmic‐type actin 4; ALFC2 = anti‐lipopolysaccharide factor 2; APOD‐like = apolipoprotein D‐like; ArthHc = athropod hemocyanin; C2H2‐type protein = C2H2‐type domain‐containing protein; CHY = chymotrypsin; CHY2B = chymotrypsin BII; CP1A = carboxypeptidase A; CTNS = cystinosin homolog; ENPP6 = ectonucleotide pyrophosphatase/phosphodiesterase family member 6; ENPP6‐like = glycerophosphocholine cholinephosphodiesterase; FABP = fatty acids binding protein; GAL3ST = putative galactose‐3‐O‐sulfotransferase; glucan PRLP = glucan pattern‐recognition lipoprotein; H1 = Histone 1; H1.0‐B‐like = putative histone H1.0‐B‐like; HcV4 = hemocyanin V4; IVL = involucrin; MEP = metalloendopeptidase; MT = metallothionein; MT1 = metallothionein 1‐like; PPA = inorganic pyrophosphatase; SLIT2‐like = slit homolog 2 protein‐like; TG1 = thyroglobulin type‐1; TLSP2 = trypsin‐like serine proteinase 2; UNCH = uncharacterized protein; ZBED8 = ZBED8 protein; ZBED8 X1 = ZBED8 isoform X1 protein (note transcripts with an unknown function are annotated with their Trinity contig ID).
Figure 5Base excision repair pathway (ko03410; which repairs DNA damage caused by oxidation and alkylation from endo‐ and exogenous sources), highlighting differentially abundant transcripts (green indicates a decrease in abundance and red indicates an increase). (A) The 24‐h exposure period saw a significant decrease in pathway transcript abundance, compared to (B) the 72‐h recovery period, which saw a significant increase. AlkA = DNA‐3‐methyladenine glycosylase II; APE1/APEX = AP endonuclease 1; APE2 = AP endonuclease 2; DpoI = DNA polymerase I; Fen1 = flapendonuclease‐1; Fpg = formamidopyrimidine‐DNA glycosylase; HMGB1 = high mobility group protein B1; Lig = DNA ligase; Lig1 = DNA ligase 1; Lig3 = DNA ligase 3; MBD4 = methyl‐CpG‐binding domain protein 4; MPG = DNA‐3‐methyladenine glycosylase; Mug = double‐stranded uracil‐DNA glycosylase; MUTY = A/G‐specific adenine glycosylase; Nei = endonuclease VIII; NEIL1 = endonuclease VIII‐like 1; NEIL2 = endonuclease VIII‐like 2; NEIL3 = endonuclease VIII‐like 3; Nfo = deoxyribonuclease IV; NTH = endonuclease III; OGG1 = N‐glycosylase/DNA lyase; PARP = poly [ADP‐ribose] polymerase 1; PCNA = proliferating cell nuclear antigen; Polβ = DNA polymerase beta; Polλ = DNA polymerase lamba; Polδ = DNA polymerase delta subunit 1; Polε = DNA polymerase epsilon subunit 1; RecJ = single‐stranded‐DNA‐specfic exonuclease; SMU = single‐strand selective monofunctional uracil DNA glycosylase; Tag = DNA‐3‐methyladenine glycosylase I; TDG = thymine‐DNA glycosylase; Udg = uracil‐DNA glycosylase; UNG = uracil‐DNA glycosylase; XRCC1 = DNA‐repair protein XRCC1; Xth = exodeoxyribonuclease III.
Quantitative and semiquantitative scores for multiple pathologies observed in hepatopancreas and gill tissues
| Hepatopancreas | |||||||
|---|---|---|---|---|---|---|---|
| R‐Cell | Gill | ||||||
| Time (h) | Nominal concentration (mg/kg) | Lumen area (% ± SE) |
Tissue degeneration (±SE) |
General integrity (±SE) |
Cellular integrity (±SE) | Nuclear pleomorphism (±SE) | Epithelial lifting (±SE) |
| Exposure (24) | Control | 24.0 ± 5.9 | 1.9 ± 0.3 | 2.7 ± 0.3 | 2.7 ± 0.2 | 3.0 ± 0.2 | 1.2 ± 0.2 |
| Exposure (24) | 0.5 | 30.1 ± 2.8 ↑ | 2.3 ± 0.5 ↑ | 2.8 ± 0.1 ↑ | 3.1 ± 0.04 ↑ | 3.1 ± 0.1 ↑ | 1.5 ± 0.3 ↑ |
| Exposure (24) | 2 | 31.1 ± 4.0 ↑ | 2.3 ± 0.2 ↑ | 2.8 ± 0.03 ↑ | 3.0 ± 0.2 ↑ | 3.1 ± 0.1 ↑ | 2.3 ± 0.7 ↑ |
| Exposure (90) | Control | 40.9 ± 9.4 | 3.5 ± 0.2 | 3.2 ± 0.2 | 3.3 ± 0.1 | 3.2 ± 0.2 | 2.5 ± 0.6 |
| Exposure (90) | 0.5 | 33.4 ± 5.6 | 2.9 ± 0.4 | 3.0 ± 0.2 | 3.3 ± 0.1 | 3.3 ± 0.1 ↑ | 1.6 ± 0.1 |
| Exposure (90) | 2 | 38.7 ± 2.9 | 3.3 ± 0.2 | 3.2 ± 0.1 | 3.4 ± 0.1 | 3.3 ± 0.1 ↑ | 2.7 ± 0.5 ↑ |
| Recovery (24) | Control | 28.4 ± 0.8a | 2.5 ± 0.5 | 2.7 ± 0.2 | 3.0 ± 0.1 | 3.1 ± 0.1 | 2.5 ± 0.4 |
| Recovery (24) | 0.5 | 40.1 ± 5.6 ↑ab | 3.1 ± 0.3 ↑ | 3.2 ± 0.2 ↑ | 3.4 ± 0.1 ↑ | 3.3 ± 0.1 ↑ | 2.7 ± 0.4 ↑ |
| Recovery (24) | 2 | 41.7 ± 3.8 ↑b | 3.2 ± 0.2 ↑ | 3.0 ± 0.1 ↑ | 3.3 ± 0.1 ↑ | 3.4 ± 0.04 ↑ | 2.6 ± 0.4 ↑ |
| Recovery (72) | Control | 34.4 ± 3.4 | 3.1 ± 0.2 | 2.9 ± 0.1 | 3.2 ± 0.1 | 3.1 ± 0.1 | 2.6 ± 0.4 |
| Recovery (72) | 0.5 | 41.4 ± 6.8 ↑ | 3.4 ± 0.2 ↑ | 3.1 ± 0.2 ↑ | 3.4 ± 0.1 ↑ | 3.2 ± 0.1 ↑ | 2.1 ± 0.5 |
| Recovery (72) | 2 | 40.7 ± 3.0 ↑ | 3.5 ± 0.04 ↑ | 3.1 ± 0.1 ↑ | 3.4 ± 0.1 ↑ | 3.2 ± 0.1 ↑ | 2.4 ± 0.2 |
Arrows indicate a potential trend in increase of pathology relative to 0 mg/kg control values.
Internal lumen area as percentage of the total digestive tubule area.
Semiquantitative scale for digestive cell degeneration tissue loss (Supporting Information).
Semiquantitative R‐cell general integrity scale (Mazurová et al., 2010).
Semiquantitative R‐cell cellular integrity scale (Mazurová et al., 2010).
Semiquantitative R‐cell nuclear pleomorphism scale (Mazurová et al., 2010).
Semiquantitative scale for gill epithelial lifting (Supporting Information).
Significant differences (p > 0.05) are indicated by letters.
Figure 6(A) Hepatopancreas (24 h of exposure control) showing small signs of lumen debris (LB), tissue degeneration (TD), lumen fracture (LF), and enlarged B cells. (B) Hepatopancreas (24 h of recovery low treatment) showing significant tissue loss (TL) and degeneration (TD), lumen debris (LB), and enlarged B cells. (C) Percentage lumen area of hepatopancreas tubules at three time points for different crude oil exposure treatments. Significant differences (p > 0.05) between treatments for individual exposure and recovery time points are indicated by letters.